Abstract:As an important biomarker for early Alzheimer’s disease (AD) diagnostics and a valuable therapeutic target, amyloid β peptide (Aβ) in blood has attracted extensive attention concerning its detection and monitoring. The tough challenges for monitoring subtle changes of Aβ in blood are low expression and high interference from environmental factors. Here, we constructed a ratiometric sensor based on dual-emission luminescent lanthanide metal–organic coordination polymer (DE-LMOCP) as fluorescence probe for simple, sensitive and accurate detection of Aβ. The DE-LMOCP (luminol-Tb-GMP-Cu) fluorescent probe was composed of terbium ion(Tb3+) as the center metal ions, cupric ion(Cu2+) as a cofactor for Tb3+ fluorescence silence, guanine monophosphate (GMP) as a bridging ligand can strengthen the fluorescence of Tb3+, and luminol as an auxiliary ligand. In the DE-LMOCP fluorescent probe, the fluorescence of the GMP-Tb is quite weak because the existing cofactor Cu2+ prevents the energy transfer of intramolecular between GMP and Tb3+ and results in the quench of GMP-Tb fluorescence. The fluorescence of luminol acts as inner reference. In the presence of Aβ, the high binding affinity of Aβ for Cu2+ causes a remarkable emission enhancement of GMP-Tb and suppresses the quenching effect. However, the fluorescence emission of luminol remains constant as inner reference. Hence, sensitive and accurate determination of Aβ were performed by the ratio of the fluorescence of luminol (F430) to the Tb3+(F547). With this ratiometric probe, Aβ was determined with sensitivity down to 20 pM. Moreover, the ratiometric probe was successfully used to the detection of Aβ in human plasma with satisfactory results due to its capability to eliminate auto-fluorescence. Significantly, it exhibited sound specificity and selectivity to recognize Aβ1−40, and successfully applied to visual detection of Aβ, which validates the potential on-site application. Given the analytical characteristics with high sensitivity, specificity, and accuracy, the ratiometric fluorescence sensor may have great potential in applications of Aβ1−40 detection and the early diagnosis of Alzheimer’s disease, as well as point-of-care tests.

UiO-66-NH2 Metal-Organic Framework for the Detection of Alzheimer's Biomarker Aβ (1-42)

Ultrasensitive electrochemical detection of amyloid-beta oligomers using double amplification strategy by MXene substrate and covalent organic framework-based probe

Covalent organic framework-based ratiometric electrochemical sensing platform for ultrasensitive determination of amyloid-β 42 oligomer

Covalent Organic Framework-Based Ratiometric Electrochemical Sensing Platform for Ultrasensitive Determination of Amyloid-(3 42 Oligomer

Electrochemiluminescence Immunosensor of “Signal-Off” for Β-Amyloid Detection Based on Dual Metal-Organic Frameworks

Molecularly Imprinted Sensor Based on Poly-O-phenylenediamine-hydroquinone Polymer for Β-Amyloid-42 Detection

In-situ nanozyme catalytic amplification coupled with a universal antibody orientation strategy based electrochemical immunosensor for AD-related biomarker

Hybridization chain reaction triggered poly adenine to absorb silver nanoparticles for label-free electrochemical detection of Alzheimer's disease biomarkers amyloid β-peptide oligomers

Freestanding Nanofiber‐Assembled Aptasensor for Precisely and Ultrafast Electrochemical Detection of Alzheimer's Disease Biomarkers

Colorimetric determination of amyloid-β peptide using MOF-derived nanozyme based on porous ZnO-Co3O4 nanocages

Highly sensitive in-situ growth gold dendrite structure electrochemical sensor for early Alzheimer's disease screening

Fe 3 O 4 /MXene Nanosphere-Based Microfluidic Chip for the Accurate Diagnosis of Alzheimer’s Disease

A Novel Electrochemical Biosensor with Molecularly Imprinted Polymers and Aptamer-Based Sandwich Assay for Determining Amyloid-Β Oligomer

Dual-mode transfer response based on electrochemical and fluorescence signals for the detection of amyloid-beta oligomers (AβO)

Detection of Amyloid-β(1–42) Aggregation With a Nanostructured Electrochemical Sandwich Immunoassay Biosensor

Implementation of an ultra-sensitive microwell-based electrochemical sensor for the detection of Alzheimer's disease

Ultrasensitive Detection of Alzheimer’s Amyloids on a Plasmonic-Gold Platform

A Hydrogel Biosensor for High Selective and Sensitive Detection of Amyloid-Beta Oligomers

Fe3O4/MXene Nanosphere-Based Microfluidic Chip for the Accurate Diagnosis of Alzheimer’s Disease

Efficient ratiometric fluorescence probe based on dual-emission luminescent lanthanide coordination polymer for amyloid β-peptide detection

Aptamer-Functionalized Carbon Nanotube Field-Effect Transistor Biosensors for Alzheimer’s Disease Serum Biomarker Detection